Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 5;24(5):5003.
doi: 10.3390/ijms24055003.

In Silico Screening and Molecular Dynamics Simulation Studies in the Identification of Natural Compound Inhibitors Targeting the Human Norovirus RdRp Protein to Fight Gastroenteritis

Affiliations

In Silico Screening and Molecular Dynamics Simulation Studies in the Identification of Natural Compound Inhibitors Targeting the Human Norovirus RdRp Protein to Fight Gastroenteritis

Rami J Obaid et al. Int J Mol Sci. .

Abstract

Norovirus (HNoV) is a leading cause of gastroenteritis globally, and there are currently no treatment options or vaccines available to combat it. RNA-dependent RNA polymerase (RdRp), one of the viral proteins that direct viral replication, is a feasible target for therapeutic development. Despite the discovery of a small number of HNoV RdRp inhibitors, the majority of them have been found to possess a little effect on viral replication, owing to low cell penetrability and drug-likeness. Therefore, antiviral agents that target RdRp are in high demand. For this purpose, we used in silico screening of a library of 473 natural compounds targeting the RdRp active site. The top two compounds, ZINC66112069 and ZINC69481850, were chosen based on their binding energy (BE), physicochemical and drug-likeness properties, and molecular interactions. ZINC66112069 and ZINC69481850 interacted with key residues of RdRp with BEs of -9.7, and -9.4 kcal/mol, respectively, while the positive control had a BE of -9.0 kcal/mol with RdRp. In addition, hits interacted with key residues of RdRp and shared several residues with the PPNDS, the positive control. Furthermore, the docked complexes showed good stability during the molecular dynamic simulation of 100 ns. ZINC66112069 and ZINC69481850 could be proven as potential inhibitors of the HNoV RdRp in future antiviral medication development investigations.

Keywords: Norovirus; RdRp; gastroenteritis; natural compounds; viral replication.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of study design.
Figure 2
Figure 2
Visualization of ZINC66112069 in RdRp’s active site. 3D views of whole protein and ligand interactions (A), 3D views of interacting residues of the RdRp active site with ZINC66112069 (B), and 2D views of the RdRp residue interacting with ZINC66112069 (C).
Figure 3
Figure 3
Visualization of ZINC69481850 in RdRp’s active site. 3D views of whole protein and ligand interactions (A), 3D views of interacting residues of the RdRp active site with ZINC69481850 (B), and 2D views of the RdRp residue interacting with ZINC69481850 (C).
Figure 4
Figure 4
Visualization of PPNDS in RdRp’s active site. 3D views of whole protein and ligand interactions (A), 3D views of interacting residues of the RdRp active site with PPNDS (B), and 2D views of the RdRp residue interacting with PPNDS (C).
Figure 5
Figure 5
Complex structural stability studies. Protein backbone RMSD (A), Ligand RMSD plot (B), and RMSF of proteins (C). Control, ZINC69481850, and ZINC66112069 were shown in blue, red, and orange colors, respectively.
Figure 6
Figure 6
Radius of gyration of complexes (A), Number of H-Bonds in complexes (B), SASA plot (C), and Number of H-Bonds between RdRp and water molecules (D). PPNDS, ZINC69481850, and ZINC66112069 were shown in blue, red, and orange colors, respectively.

References

    1. Lopman B.A., Steele D., Kirkwood C.D., Parashar U.D. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control. PLoS Med. 2016;13:e1001999. doi: 10.1371/journal.pmed.1001999. - DOI - PMC - PubMed
    1. Petrignani M., Verhoef L., de Graaf M., Richardus J.H., Koopmans M. Chronic sequelae and severe complications of norovirus infection: A systematic review of literature. J. Clin. Virol. 2018;105:1–10. doi: 10.1016/j.jcv.2018.05.004. - DOI - PubMed
    1. Shah M.P., Hall A.J. Norovirus Illnesses in Children and Adolescents. Infect. Dis. Clin. N. Am. 2018;32:103–118. doi: 10.1016/j.idc.2017.11.004. - DOI - PMC - PubMed
    1. Khayat A.A., Telega G.W. Persistent elevation of aminotransferases in liver transplant in association with chronic norovirus infection. Clin. Mol. Hepatol. 2019;25:408–411. doi: 10.3350/cmh.2019.0018. - DOI - PMC - PubMed
    1. Lucero Y., Vidal R., O’Ryan G.M. Norovirus vaccines under development. Vaccine. 2018;36:5435–5441. doi: 10.1016/j.vaccine.2017.06.043. - DOI - PubMed

Substances